Susquehanna Portfolio Strategies, LLC Stoke Therapeutics, Inc. Transaction History
Susquehanna Portfolio Strategies, LLC
- $4.3 Trillion
- Q1 2024
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 43,424 shares of STOK stock, worth $586,658. This represents 0.01% of its overall portfolio holdings.
Number of Shares
43,424
Previous 45,108
3.73%
Holding current value
$586,658
Previous $237 Million
147.07%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding STOK
# of Institutions
111Shares Held
50MCall Options Held
63KPut Options Held
111K-
Skorpios Trust14.4MShares$195 Million99.92% of portfolio
-
Redmile Group, LLC San Francisco, CA5.07MShares$68.5 Million2.7% of portfolio
-
Rtw Investments, LP New York, NY4.22MShares$57.1 Million0.92% of portfolio
-
Morgan Stanley New York, NY4.03MShares$54.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$52.1 Million0.0% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $533M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...